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TWELVE  FACTS THAT EVERY DOCOTOR OF DENTAL 
MEDICINE SHOULD KNOW ABOUT THE ORAL CAVITY 
CARCINOMA
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Summary
The most frequent malignant tumor of the oral cavity is squamous cell carcinoma, tumor 
that should be easy recognizable and treated successfully if diagnosed at an early stage. Un-
fortunately, many of this tumors remain unrecognized until advanced stages when treatment 
demands extensive surgery or chemoradiotherapy. Treating oral cancer in late stages is often 
combined  with  poor outcomes, incomplete recovery and lower quality of life. The authors 
outline the most important questions necessary for early diagnosis and better understanding 
of the disease with a goal of preventing delayed diagnosis or misdiagnosis of an oral cavity 
cancer.
Key words: oral cavity carcinoma; precancerosis; diagnosis; metastatic potential; tre-
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INTRODUCTION
Our goal is to discover oral cancer before patients present with pain, a mass, 
bleeding, otalgia or dysphagia. A thorough, systematic examination of the mouth 
and neck takes only a few minutes and can detect cancer at an early and curable 
stage.  Errors in diagnosis are most often the ones of omission and therefore, the 
importance of a systematic approach to the oral, head and neck examination cannot 
be overemphasized.
THE TWELVE FACTS
Twelve facts are outlined in this text that we consider most important for dental 
medicine practitioners to be aware of. The knowledge of these facts should reduce 
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the number of patients seen in everyday practice that were not diagnosed in a timely 
manner or were mistreated for prolonged period of time and should enable better 
understanding of the disease.
This text leads through the twelve questions that are easy to memorize and are 
to be considered during examination in a daily routine as well as follow-up.
1. Who are the patients?  
Mostly, it is a population of alcohol and/or cigarette abusers that make over 90% 
of patients diagnosed with oral cavity cancer. People who use both tobacco and alco-
hol are at greater risk then people who use them alone. Additionally, many of those 
ignore the symptoms until in very developed stage of the disease with bleeding 
and/or dysphagia. Based on the information gathered from our database; over 90% 
of the patients in our population are male, over 40 years of age, cigarettes and alco-
hol abusers (Figure 1.) One study from France showed that extremely heavy drinkers 
(greater than 100 grams of alcohol per day) had a 30 times greater risk of developing 
oral and oropharyngeal cancer (a typical serving of beer, wine or liquor contains 
10 to 15 grams of alcohol), [1]. Of even greater significance is the synergistic effect 
of alcohol and smoking; some subsets of patients who are both heavy smokers and 
heavy drinkers can have over one hundred times greater risk for developing a ma-
lignancy [1,2].
 Figure 1.  Predominant type of patients.
63
Rad 514 Medical Sciences, 38(2012) : 61-68
M. Virag et al: Twelve facts that every doctor of dental medicine should...
2.  What is the role of Human Papilloma Virus in development of oral cavity 
cancer?  
Recently some very strong evidence has shown that HPV-positive oropharynge-
al cancers comprise a distinct molecular, clinical and pathologic disease entity that 
is causally associated with HPV infection [3-7]. It is also stressed that the incidence 
of tonsillar carcinoma is increasing despite a decline in tobacco use, supporting the 
existence of other important risk factors such as HPV infection [8]. The group of 
French authors did a research on Human Papilloma Virus genotype distribution in 
oropharynx and oral cavity cancer in France with the results of overall HPV pre-
valence of 46.5% in oropharyngeal carcinomas and 10.5% in oral cavity carcinomas 
and higher prevalence in female than in male cases (63.5% vs 42.2% in oropharynx 
and 17.2% vs 8.0% in oral cavity), [9].  HPV-16 has been detected in up to 22 percent 
of oral cancers, and HPV-18 has been found in up to 14 percent of cases [4].  HPV 
is mostly associated with oral cavity carcinomas at younger age and carries better 
prognosis. The question remains whether HPV vaccination will diminish the incre-
asing number of this diagnosis.
3. Which factors do not lead to the development of oral cavity cancer? 
Opposite to the common understanding and many textbooks, irritation of the 
mucosa due to dental prothesis, carious teeth or spiced food do not promote the 
development of oral cavity cancer.
4. Where is initial carcinoma situated? 
It almost always begins on the thin mucosa that covers the floor of the mouth, 
ventral side of the tongue and palatal arches. It is suggested that there is a greater 
incidence of oral cavity carcinoma at the lower portions of the oral cavity where 
saliva is accumulated together with all its potentially containing carcinogens (e.g. 
alcohol, tobacco). This  “pool” of saliva is not being exposed to  carcinogenic effect 
of alcohol only during the consumption period (up to 20 minutes) but also after the 
reabsorption where the effect of saliva excreted alcohol at the floor of the mouth 
lasts approximately 7,7 hours [10,11]. Moreover, the floor of the mouth is covered by 
a thinner, nonkeratinized mucosa, which provides less protection against carcino-
gens. Tobacco/alcohol lesions tend to favor the anterior tongue and mouth, and HPV 
positive lesions tend to favor the posterior oral cavity.  Benign lesions occurring on 
the dorsum of the tongue have at times been diagnosed as carcinoma. A retrospecti-
ve study has shown that the occurrence of primary carcinoma on the dorsum of the 
tongue is an extremly rare entity. It may be erroneously diagnosed in cases of me-
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dian rhomboid glossitis, granular cell myoblastoma and any other lesion associated 
with pseudoepitheliomatous hyperplasia. These conditions should always be con-
sidered when examining lesions in this location. Histological diagnosis, although 
difficult, is greatly facilitated by good biopsy technique but, above all, good liaison 
between surgeon, radiotherapist and pathologist is essential if these mistakes in 
diagnosis are to be avoided [12].
5. Which are the precanceroses?
Multiple studies have consistently shown that the earliest manifestation of 
many oral and oropharyngeal squamous cell cancers is a persistent erythroplastic 
lesion. It is a reddish lesion that either precedes to or already is a carcinoma. Leu-
koplakia or lichen planus are also precancersous lesions, but the incidence of mali-
gnant transformation is much lower (less than 10%). As defined by the World Health 
Organization, leukoplakia is “a white patch or plaque that cannot be characterized 
clinically or pathologically as any other disease” [13].  As such, leukoplakia should 
be used only as a clinical term [14]. In the evaluation of the patient, leukoplakia is a 
clinical diagnosis of exclusion.  Similar to this definition, erythroplakia is a clinical 
term that refers to a red patch that cannot be defined clinically or pathologically as 
any other condition [13].  This definition excludes inflammatory conditions that may 
result in a red clinical appearance. Some lesions may be intermixed with white areas 
(erythroleukoplakia). Clinicians must therefore be on the lookout for both red and 
white (leukoplakia) lesions on the oral mucosa, as well as detection through palpa-
tion of indurated and fixed masses within the tissues [15].
6. How does the initial carcinoma looks like? 
At the earliest stage it is the superficial, reddish, vulnerable, velvet lesion - eryt-
hroplakia, later the ulcer develops. As the lesion grows, it may become an exophytic 
mass with a fungating or papillary surface or an endophytic mass characterized 
by a depressed, ulcerated surface with a raised, rolled border. The evolving cancer 
slowly becomes a crusted, nontender, often totally asymptomatic, specially at an 
early stage. Squamous cell carcinoma is never to be found under the intact mucosal 
layer. 
7.  How often does the general or dental medicine practitioner makes the dia-
gnosis of  oral cavity cancer? 
Unfortunately, rarely. At least 2/3 of the patients were not diagnosed as carcino-
ma during the initial examination [16].
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8.  What is the differential diagnosis in patients with unclear or atypical clinical 
picture?  
There are many benign tissue changes that occur in the mouth, and things as 
simple as a bite on the inside of the cheek may mimic the look of a dangerous ti-
ssue change. Traumatic ulcer should always be taken in consideration, thorough 
examination should reveal the possible cause. Necrotizing sialometaplasia (NS) is 
a nonneoplastic inflammatory condition of the salivary glands. In 1973, Abrams et 
al first reported on this condition [17]. Both clinical and histopathologic features of 
necrotizing sialometaplasia often mimic those of malignancies such as squamous 
cell carcinoma or salivary gland malignancy. All subsequent reports of necrotizing 
sialometaplasia stress the importance of correct diagnosis.  Familiarity with necroti-
zing sialometaplasia and correct diagnosis are paramount in avoiding misdiagnosis 
and over- treatment. Ischemia of salivary gland tissue leading to infarction (trauma) 
is the most likely cause. In small salivary glands tumors, when lesion becomes larger 
it can ulcerate the mucosal layer making it difficult to determine their submucosal 
origin. Also, pathology such as mucosal melanoma can be presented as a pigmented 
or non-pigmented lesion of oral mucosa. 
9. How high is the risk of metastasis?
Fortunately, low. About 40 % of our patients  have regional (lymph node) meta-
stases  which are in most cases surgically curable and in less than the 1% metastases 
are distant and thus incurable.
10. How do we treat oral cancer? 
Depending on the stage and grade of the tumor the decision is made whether 
to operate only the primary tumor or to include lymph nodes and preform a neck 
dissection as well. (See TNM classification, Table 1).  Extensive “commando” opera-
tion which involves resection of the tumor, cervical lymph nodes and often partial 
resection of the mandible is necessary only at the developed stages of the carcino-
ma. Smaller tumors can be removed as radically with a peroral approach with much 
better functional and aesthetic outcomes.  Radiation and chemotherapy options may 
be used adjunctively or palliatively. For some tumors radiation therapy is also an 
option for curative treatment.
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Table 1.  TNM Classification - Oral cavity UICC/AJCC 2002.
T1 2 cm or less
T2 > 2 to 4 cm
T3 > 4 cm
T4a  invades adjacent structures: 
cortical bone, deep muscles of tongue, maxillary sinus, skin of face
T4b  invades adjacent structures: 
Masticator space, pterygoid plates, skull base, internal carotid artery
N0 no metastasis
N1  homolateral, single, ≤ 3 cm
N2 
N2a  homolateral, single,  >3 to 6 cm
N2b  homolateral, single, ≤  6 cm
N2c  homo and/or contralateral, ≤  6 cm
N3  > 6 cm
    M0 no distant metastasis 
    M1 distant metastasis
11. What about the prognosis? 
This depends on the stage of the disease. At stage I, over 80 % of the patients are 
cured. Every following stage diminishes the prognosis for 20%  down to only 20% 
successfully treated at the stage IV. Patients with cancers treated in the early stages 
have less post-treatment disfigurement.
12. How long  do we follow-up patients after initial treatment? 
Lifelong. Almost all of the local reccurences and metastases occur in first two 
years, but monitoring should be continued for most of the patients have high suscep-
tibility to develop a new primary tumor of the upper gastrointestinal or respiratory 
tract as a result of field cancerization. New primary carcinoma is seen in almost 30% 
of cured patients and the regular monitoring is the best way for early diagnosis and 
a basis for a successful treatment of the newly developed tumors. 
CONCLUSION
The most important message is that early detection of the asymptomatic stage 
oral cancer translates in general terms to satisfactory clinical outcome and cure in 
most patients.
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Unfortunately, there has been little improvement in the early detection of oral 
cancer because many patients ignore their symptoms until at very late stage of the 
disease and both the general practitioners and dentists lack the necessary knowl-
edge and experience.  In order to improve oral cancer survival, public education ef-
forts are also necessary to encourage patients to avoid high risk behaviors and to ask 
their health care providers about regular oral cancer screening examinations. The 
ability to control oral and oropharyngeal cancer will depend on two cornerstones: 
prevention and early diagnosis.
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Sažetak
Dvanaest činjenica koje bi svaki doktor dentalne medicine trebao znati o 
karcinomu usne šupljine
Planocelularni karcinom, nesumljivo najčešći karcinom usne šupljine, vjerojatno je je-
dan od tumora koji bi se trebao najlakše prepoznati i uspješno liječiti. Nažalost, niti jed-
no nije stvarnost, mnogi od ovih tumora prepoznaju se u kasnim stadijima kada liječenje 
zahtjeva opsežan operativni zahvat ili kemoradioterapiju. Liječenje karcinoma usne šupljine 
u kasnim stadijima često je povezano sa visokom stopom smrtnosti, a u mnogim slučajevima 
znači nepotpun oporavak i smanjenu kvalitetu života. U ovom članku, autori žele naglasiti 
najvažnija pitanja koja su neophodna za rano prepoznavanje i bolje razumijevanje bolesti 
kako bi se preveniralo pogrešno dijagnosticiranje i kasno otkrivanje karcinoma usne šupljine.
Ključne riječi: karcinom usne šupljine; prekanceroze; dijagnoza; metastatski potencijal; 
liječenje; prognoza.
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